Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC
GLOBETECH MEDIA

New Molecular Biology Tool Eases Preparation of Chromatin-DNA Complexes

By BiotechDaily International staff writers
Posted on 21 Jul 2014
Image
Image
Biotech and other life sciences laboratories that isolate and analyze chromatin-DNA complexes will have a much easier time, as a new molecular biology tool for this purpose has now been released to the market.

The new Porvair Sciences Ltd. (Wales, United Kingdom) Chromatrap solid state ChIP (chromatin immunoprecipitation) assay is described as being more efficient, sensitive and robust than standard ChIP methods.

ChiP is a fast growing research technique and is commonly used for mapping the DNA-protein interactions in cells which are crucial for correct gene regulation. For example, they may be used to determine whether proteins such as transcription factors and modified histones bind to a particular region of DNA of living cells or tissues. In a ChIP assay, fragments of the DNA-protein complex (chromatins) are cross-linked in such a way so as to retain the specific DNA-protein interactions. The chromatin is then extracted and sheared either by sonication or enzymatic digestion into small fragments. The DNA/protein fragments are selectively immunoprecipitated using antibodies directed against the protein of interest and the resulting fractions treated to separate the DNA and protein components. Polymerase Chain Reaction (PCR), real time PCR, hybridization on microarrays, or direct sequencing are typically used to identify DNA fragments of defined sequence.

Chromatrap kits use revolutionary spin columns or microplates, which contain discs of an inert, porous polymer to which protein A or G has been covalently attached. During an assay, the chromatin/antibody complex is selectively retained by the disc. Flushing with three buffers and an elution step are all that is required to obtain the selectively enriched DNA. Chromatrap allows high quality chromatin to be obtained from as few as 7,000 cells in under five hours.

Chromatrap was developed by Porvair in association with Dr. Steve Conlan, professor of molecular and cell biology at Swansea University (United Kingdom).

Related Links:

Porvair Sciences Ltd.

Swansea University



Channels

Genomics/Proteomics

view channel
Image: Pulsed near infrared light (shown in red) is shone onto a tumor (shown in white) that is encased in blood vessels. The tumor is imaged by photoacoustic tomography via the ultrasound emission (shown in blue) from the gold nanotubes (Photo courtesy of Jing Claussen (iThera Medical, Germany)).

Gold Nanotubes Are Novel Agents for Cancer Diagnosis and Treatment

Cancer researchers have produced a highly defined class of gold nanotubes that are suitable for use in animals as in vivo imaging nanoprobes, photothermal conversion agents, and drug delivery vehicles.... Read more

Drug Discovery

view channel
Image: Molecular model of the protein Saposin C (Photo courtesy of Wikimedia Commons).

Nanovesicles Kill Human Lung Cancer Cells in Culture and in a Mouse Xenograft Model

Nanovesicles assembled from the protein Saposin C (SapC) and the phospholipid dioleoylphosphatidylserine (DOPS) were shown to be potent inhibitors of lung cancer cells in culture and in a mouse xenograft model.... Read more

Biochemistry

view channel

Possible New Target Found for Treating Brain Inflammation

Scientists have identified an enzyme that produces a class of inflammatory lipid molecules in the brain. Abnormally high levels of these molecules appear to cause a rare inherited eurodegenerative disorder, and that disorder now may be treatable if researchers can develop suitable drug candidates that suppress this enzyme.... Read more

Business

view channel

Roche Acquires Signature Diagnostics to Advance Translational Research

Roche (Basel, Switzerland) will advance translational research for next generation sequencing (NGS) diagnostics by leveraging the unique expertise of Signature Diagnostics AG (Potsdam, Germany) in biobanks and development of novel NGS diagnostic assays. Signature Diagnostics is a privately held translational oncology... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.